全球血液檢測市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計血液檢測市場將從 2025 年的 1,103 億美元成長到 2034 年的 2,270.1 億美元，2026 年至 2034 年的複合年成長率為 8.35%。

全球血液檢測市場正經歷顯著成長，這主要得益於慢性病盛行率的上升和預防醫學意識提升。定期血液檢測對於診斷糖尿病、心血管疾病和感染疾病等疾病至關重要。人口老化和全球診斷檢查室的擴張推動了對先進血液檢測解決方案的需求。自動化分析儀和快速診斷試劑盒的技術創新也進一步促進了市場擴張。

關鍵成長要素包括醫療費用支出增加、對疾病早期檢測的需求不斷成長以及就地檢驗服務的擴展。政府推行的促進定期健康檢查和改善農村地區診斷服務可近性的政策正在推動市場發展。此外，分子診斷技術和個人化醫療的進步正在拓展血液檢測的應用範圍。家用檢測套組的廣泛普及也促進了產業成長。

展望未來，人工智慧（AI）、數位健康平台和檢查室自動化技術的整合預計將推動市場呈現強勁成長動能。遠端醫療服務的擴展和分散式檢查模式的普及將創造新的機會。生物標記發現和精準診斷領域的持續研究將進一步提升市場成長潛力。隨著預防醫學日益受到重視，血液檢測市場將繼續在全球醫療診斷領域中佔有重要地位。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球血液檢測市場：依檢測類型分類

• 市場分析、洞察與預測
• 血脂檢查
• 攝護腺特異性抗原
• 冠狀病毒感染疾病（COVID-19）
• 血液常規檢查（CBC）
• 血中尿素氮（BUN）檢測
• 血糖測試
• A1c
• 直接低密度脂蛋白
• 皮質醇
• 肌酸酐
• 其他測試

第5章 全球血液檢測市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院
• 診所
• 診斷中心
• 研究所
• 其他（血庫）

第6章 全球血液檢測市場：依檢測方法分類

• 市場分析、洞察與預測
• 手動的
• 自動化

第7章 全球血液檢測市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Abbott Diagnostics
  • Bio-Rad Laboratories Inc
  • Roche Diagnostics
  • Quest Diagnostics
  • Danaher Corporation
  • Becton Dickinson & Company
  • Biomerica Inc
  • BioMAfA（C）Rieux SA
  • Siemens Healthcare
  • Trinity Biotech PLC

The Blood Testing Market size is expected to reach USD 227.01 Billion in 2034 from USD 110.30 Billion (2025) growing at a CAGR of 8.35% during 2026-2034.

The Global Blood Testing Market is experiencing substantial growth driven by increasing prevalence of chronic diseases and rising awareness about preventive healthcare. Routine blood tests are essential for diagnosing conditions such as diabetes, cardiovascular disorders, and infections. The growing geriatric population and expansion of diagnostic laboratories worldwide are fueling demand for advanced blood testing solutions. Technological innovations in automated analyzers and rapid diagnostic kits are further supporting market expansion.

Major growth drivers include increasing healthcare expenditure, rising demand for early disease detection, and expansion of point-of-care testing services. Government initiatives promoting routine health screenings and improved access to diagnostic services in rural regions are strengthening the market landscape. Moreover, advancements in molecular diagnostics and personalized medicine are expanding the application scope of blood testing. The adoption of home-based testing kits is also contributing to industry growth.

Looking forward, the market is expected to witness strong momentum due to integration of artificial intelligence, digital health platforms, and automation in laboratories. Expansion of telehealth services and decentralized testing models will create new opportunities. Continuous research in biomarker discovery and precision diagnostics will further enhance growth potential. With increasing focus on preventive healthcare, the blood testing market will remain a cornerstone of global medical diagnostics.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Test Type

• Lipid Panel Testing
• Prostate-Specific Antigen
• Covid-19
• Complete Blood Count (CBC)
• Bun Testing (Blood Urea Nitrogen)
• Glucose Testing
• A1c
• Direct Ldl
• Cortisol
• Creatinine
• Others Tests

By End User

• Hospitals
• Clinics
• Diagnostic Centre
• Research Laboratories
• Others (Blood Banks)

By Method

• Manual
• Automated

COMPANIES PROFILED

• Abbott Diagnostics, BioRad Laboratories Inc, Roche Diagnostics, Quest Diagnostics, Danaher Corporation, Becton Dickinson Company, Biomerica Inc, bioMrieux SA, Siemens Healthcare, Trinity Biotech PLC
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BLOOD TESTING MARKET: BY TEST TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Test Type
• 4.2. Lipid Panel Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Prostate-Specific Antigen Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Covid-19 Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Complete Blood Count (CBC) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Bun Testing (Blood Urea Nitrogen) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Glucose Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. A1c Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.9. Direct Ldl Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.10. Cortisol Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.11. Creatinine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.12. Others Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BLOOD TESTING MARKET: BY END USER 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End User
• 5.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Diagnostic Centre Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Research Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Others (Blood Banks) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BLOOD TESTING MARKET: BY METHOD 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Method
• 6.2. Manual Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Automated Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BLOOD TESTING MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Test Type
  • 7.2.2 By End User
  • 7.2.3 By Method
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Test Type
  • 7.3.2 By End User
  • 7.3.3 By Method
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Test Type
  • 7.4.2 By End User
  • 7.4.3 By Method
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Test Type
  • 7.5.2 By End User
  • 7.5.3 By Method
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Test Type
  • 7.6.2 By End User
  • 7.6.3 By Method
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL BLOOD TESTING INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Abbott Diagnostics
  • 9.2.2 Bio-Rad Laboratories Inc
  • 9.2.3 Roche Diagnostics
  • 9.2.4 Quest Diagnostics
  • 9.2.5 Danaher Corporation
  • 9.2.6 Becton Dickinson & Company
  • 9.2.7 Biomerica Inc
  • 9.2.8 BioMAfA(C)Rieux S.A
  • 9.2.9 Siemens Healthcare
  • 9.2.10 Trinity Biotech PLC